Newly diagnosed rheumatic heart disease among indigenous populations in the Pacific

Autor: Isabelle Missotte, Mariana Mirabel, Eloi Marijon, Baptiste Noël, Jean-Philippe Empana, Tom Parks, Thierry Jubeau, Gwendolyne Phelippeau, Corinne Braunstein, Xavier Jouven, Shirley Gervolino, Olivier Axler, Marie Nadra, Jacques Robert, Cécile Cazorla, Bernard Rouchon, Sylvie Laumond, Elodie Descloux, Yann Barguil, Muriel Tafflet
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Adult
Male
Pediatrics
medicine.medical_specialty
Cardiac & Cardiovascular Systems
Heart disease
Adolescent
Population
Severity of Illness Index
Cohort Studies
FEVER
New Caledonia
Severity of illness
Outcome Assessment
Health Care

medicine
MANAGEMENT
Secondary Prevention
CRITERIA
Humans
Registries
education
INFECTIVE ENDOCARDITIS
1102 Cardiorespiratory Medicine and Haematology
Demography
education.field_of_study
Science & Technology
business.industry
Incidence (epidemiology)
Incidence
Rheumatic Heart Disease
1103 Clinical Sciences
medicine.disease
Hospitalization
Embolism
Socioeconomic Factors
Cardiovascular System & Hematology
Cardiovascular Diseases
Echocardiography
Heart failure
Valvular Heart Disease
Cardiovascular System & Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Life Sciences & Biomedicine
Mace
Cohort study
CARDIAC-SURGERY
Zdroj: Heart
Popis: Objectives Rheumatic heart disease (RHD) remains the leading acquired heart disease in the young worldwide. We aimed at assessing outcomes and influencing factors in the contemporary era. Methods Hospital-based cohort in a high-income island nation where RHD remains endemic and the population is captive. All patients admitted with newly diagnosed RHD according to World Heart Federation echocardiographic criteria were enrolled (2005–2013). The incidence of major cardiovascular events (MACEs) including heart failure, peripheral embolism, stroke, heart valve intervention and cardiovascular death was calculated, and their determinants identified. Results Of the 396 patients, 43.9% were male with median age 18 years (IQR 10–40)). 127 (32.1%) patients presented with mild, 131 (33.1%) with moderate and 138 (34.8%) with severe heart valve disease. 205 (51.8%) had features of acute rheumatic fever. 106 (26.8%) presented with at least one MACE. Among the remaining 290 patients, after a median follow-up period of 4.08 (95% CI 1.84 to 6.84) years, 7 patients (2.4%) died and 62 (21.4%) had a first MACE. The annual incidence of first MACE and of heart failure were 59.05‰ (95% CI 44.35 to 73.75) and 29.06‰ (95% CI 19.29 to 38.82), respectively. The severity of RHD at diagnosis (moderate vs mild HR 3.39 (0.95 to 12.12); severe vs mild RHD HR 10.81 (3.11 to 37.62), p
Databáze: OpenAIRE